Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Belgium,United Kingdom,United States,Finland,Canada,Former Serbia and Montenegro,Germany,Russian Federation,Romania,France
nct
Update Il y a 5 ans
A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer
The rationale of the study was to evaluate different degarelix dosing regimens for a three-month interval that was to produce and maintain castration in prostate cancer patients through immediate and prolonged testosterone suppression, and to provide confirmatory evidence of the safety of degarelix.
Country
Belgium
,
Canada
,
Finland
,
Former Serbia and Montenegro
,
France
,
Germany
,
Netherlands
,
Romania
,
Russian Federation
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
1